Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Xinhuan Chen"'
Publikováno v:
BMC Medical Education, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background International student education has become an important part of higher education and an important symbol to measure the level of higher education. To change the traditional teaching model, here we introduced a combination of Case-
Externí odkaz:
https://doaj.org/article/e5326dc7c4844350afb1e218dbfbe8fb
Autor:
Jiace Qin, Yanyan Zhu, Yongwei Ding, Tingting Niu, Yangyang Zhang, Huiting Wu, Lili Zhu, Baoyin Yuan, Yan Qiao, Jing Lu, Kangdong Liu, Ziming Dong, Ge Jin, Xinhuan Chen, Jimin Zhao
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 7, Pp 663-675 (2021)
Esophageal mucosa undergoes mild, moderate, severe dysplasia, and other precancerous lesions and eventually develops into carcinoma in situ, and understanding the developmental progress of esophageal precancerous lesions is beneficial to prevent them
Externí odkaz:
https://doaj.org/article/c0c226a145e24a17bc1ea6e50da7af4a
Autor:
Yanan Jiang, Jing Zhang, Jimin Zhao, Zhenzhen Li, Hanyong Chen, Yan Qiao, Xinhuan Chen, Kangdong Liu, Ziming Dong
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-14 (2019)
Abstract Background Esophageal squamous cell carcinoma (ESCC) is a fatal disease with poor prognosis. The predominant reason for ESCC-related death is distal metastasis. A comprehensive understanding of the molecular mechanism underlying metastasis i
Externí odkaz:
https://doaj.org/article/79696e179feb46d2891bd71f1d71dbaf
Autor:
Xiangyu Wu, Zitong Wang, Yanan Jiang, Hao Zhou, Ang Li, Yaxing Wei, Zhuo Bao, Donghao Wang, Jimin Zhao, Xinhuan Chen, Yaping Guo, Zigang Dong, Kangdong Liu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC) are the two major types of esophageal cancer (EC). ESCC accounts for 90% of EC. Recurrence after primary treatment is the main reason for poor survival. Therefore, recurren
Externí odkaz:
https://doaj.org/article/99c0be4540c5453d846d9053bdebd56c
Autor:
Ying Liu, Xinhua Wang, Shuang Zeng, Xiane Zhang, Jimin Zhao, Xiaoyan Zhang, Xinhuan Chen, Wanjing Yang, Yili Yang, Ziming Dong, Jingyu Zhu, Xin Xu, Fang Tian
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 37, Iss 1, Pp 1-12 (2018)
Abstract Background We and others have previously shown that the STAT3 signaling pathway is activated in some esophageal squamous cell carcinoma (ESCC) cells and is required for the survival and growth of these primary ESCC-derived xenografts. It has
Externí odkaz:
https://doaj.org/article/74626caeab3a499fa17c354b65038a41
Autor:
Lili Zhu, Xinhuan Chen, Yanyan Zhu, Jiace Qin, Tingting Niu, Yongwei Ding, Yang Xiao, Yanan Jiang, Kangdong Liu, Jing Lu, Wanjing Yang, Yan Qiao, Ge Jin, Junfen Ma, Ziming Dong, Jimin Zhao
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Dihydroartemisinin (DHA), a sesquiterpene lactone with endoperoxide bridge, is one of the derivatives of artemisinin. In addition to having good antimalarial properties, DHA exhibits anticancer effects including against malignant solid tumors. Howeve
Externí odkaz:
https://doaj.org/article/e25dc40e78a546c4901d58d9eb1a2bf0
Autor:
Yifei Xie, Jing Zhang, Bingbing Lu, Zhuo Bao, Jimin Zhao, Xianyu Lu, Yaxing Wei, Ke Yao, Yanan Jiang, Qiang Yuan, Xiaofan Zhang, Bo Li, Xinhuan Chen, Zigang Dong, Kangdong Liu
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Esophageal squamous cell carcinoma (ESCC) has a worldwide impact on human health, due to its high incidence and mortality. Therefore, identifying compounds to increase patients' survival rate is urgently needed. Mefloquine (MQ) is an FDA-approved ant
Externí odkaz:
https://doaj.org/article/4a587e54387c462ba7fdb3ba028f19d5
Autor:
Yanan Jiang, Jimin Zhao, Yi Zhang, Ke Li, Tiepeng Li, Xinhuan Chen, Simin Zhao, Song Zhao, Kangdong Liu, Ziming Dong
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-18 (2018)
Abstract Background The overall 5-year survival rate of lung cancer is about 15% even with therapeutic drugs like tyrosine kinase inhibitors. Ideal models are urgently needed for exploring mechanisms and finding new drugs. Patient-derived xenografts
Externí odkaz:
https://doaj.org/article/579a6adb0438436d949cb2b90e57f8ea
Autor:
Yanan Jiang, Jing Zhang, Jimin Zhao, Zhenzhen Li, Hanyong Chen, Yan Qiao, Xinhuan Chen, Kangdong Liu, Ziming Dong
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-2 (2020)
Following publication of the original article [1], the authors reported the errors in Fig. 1C and D, Fig. 2, Fig. 4B and C and Fig. 6D and E.
Externí odkaz:
https://doaj.org/article/a4216908535543e0a2537ba03b6ac66c
Autor:
Qiushuang Zhang, Chao Xie, Dongyu Wang, Yi Yang, Hangfan Liu, Kangdong Liu, Jimin Zhao, Xinhuan Chen, Xiaoyan Zhang, Wanjing Yang, Xiang Li, Fang Tian, Ziming Dong, Jing Lu
Publikováno v:
Cells, Vol 8, Iss 5, p 494 (2019)
Angiogenesis is essential for the development, growth, and metastasis of solid tumors. Vaccination with viable human umbilical vein endothelial cells (HUVECs) has been used for antitumor angiogenesis. However, the limited immune response induced by H
Externí odkaz:
https://doaj.org/article/1da4fb9c57a649bbb152cdbe1a7fedc3